Can nitric oxide production be modulated by altering L-arginine levels?
Kilbourn
R G
RG
Goldfarb
R D
RD
D000818:Animals; D001120:Arginine / Q000494:pharmacology*; D016470:Bacteremia / Q000378:metabolism / Q000503:physiopathology; D004195:Disease Models, Animal; D004730:Endothelium, Vascular / Q000378:metabolism; D006801:Humans; D009474:Neurons / Q000378:metabolism; D009569:Nitric Oxide / Q000096:biosynthesis*; D019001:Nitric Oxide Synthase / Q000187:drug effects / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II; D012756:Sheep; D012772:Shock, Septic / Q000378:metabolism* / Q000503:physiopathology; D015854:Up-Regulation; D014664:Vasodilation / Q000187:drug effects
D009569:Nitric Oxide; D001120:Arginine; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II